Project Details


Alport syndrome is a rare genetic disorder and the second most common form of inherited kidney disease. This is caused by the genes needed to create a type of collagen that plays a key role in kidney function.

Currently, there is no cure for Alport syndrome. The available treatments aim to slow the progression of kidney disease and to alleviate symptoms. There is a great need for more targeted and effective therapies to treat Alport syndrome.

The Alport Research Hub is funded by the Stoneygate Trust and Kidney Research UK, with Alport UK as a collaborator. The hub aims to transform early diagnosis and specific treatments for patients with Alport syndrome.
Effective start/end date1/04/2231/03/27

Collaborative partners


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.